Author:
Shen Hong-yu,Xu Jia-lin,Zhu Zhen,Xu Hai-ping,Liang Ming-xing,Xu Di,Chen Wen-quan,Tang Jin-hai,Fang Zheng,Zhang Jian
Reference57 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol.,2019
2. Breast cancer immunotherapy: facts and hopes;Emens;Clin. Cancer Res.,2018
3. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA;Paulson;Nat. Commun.,2018
4. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N. Engl. J. Med.,2018
5. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer;Stamm;Oncoimmunology,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献